Hepatit B'den D'ye Hep GŁncel - page 50

38
Kronik Hepatit B
2.
Ferrari C, Missale G, Boni C, Urbani S. Immunopathogenesis of hepatitis B. J
Hepatol 2003;39(Suppl1):S36-42.
3.
Webster GJ, Reignat S, Maini MK, Whalley SA, Ogg GS, King A et al. Incubation
phase of acute hepatitis B in man: dynamic of cellular immune mechanisms.
Hepatology 2000;32:1117-1124.
4.
Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV.
Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes.
Immunity 1996;4:25-36.
5.
Tang TJ, Kwekkeboom J, Laman JD, Niesters HG, Zondervan PE, De Man RA et
al. The role of intrahepatic immune effector cells in inflammatory liver injury and
viral control during chronic hepatitis B infection. J Viral Hepat 2003;10:159-167.
6.
Wieland SF, Guidotti LG, Chisari FV. Intrahepatic induction of alpha/beta
interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic
mice. J Virol 2000;74:4165-4173.
7.
Kimura K, Kakimi K, Wieland S, Guidotti LG, Chisari FV. Activated intrahepatic
antigen-presenting cells inhibit hepatitis B virus replication in the liver of
transgenic mice. J Immunol 2002;169:5188-5195.
8.
Kimura K, Kakimi K, Wieland S, Guidotti LG, Chisari FV. Interleukin-18
inhibits hepatitis B virus replication in the livers of transgenic mice. J Virol
2002;76:10702-10707.
9.
Lanzavecchia A, Sallusto F. Dynamics of T lymphocyte responses:
intermediates, effectors and memory cells. Science 2000;290:92-7.
10.
Chang JJ, Lewin SR. Immunopathogenesis of hepatitis B virus infection. Immunol
Cell Biol 2007;85:16-23.
11.
Penna A, Artini M, Cavalli A, Levrero M, Bertoletti A, Pilli M et al. Long-lasting
memory T cell responses following self-limited acute hepatitis B. J Clin Invest
1996;98:1185-1194.
12.
Thimme R, Wieland S, Steiger C, Ghrayeb J, Reimann KA, Purcell RH et al.
CD8(+) T cells mediate viral clearance and disease pathogenesis during acute
hepatitis B virus infection. J Virol 2003;77:68-76.
13.
Kakimi K, Guidotti LG, Koezuka Y, Chisari FV. Natural killer T cell activation
inhibits hepatitis B virus replication in vivo. J Exp Med 2000;192:921-930.
14.
Chisari FV, Isogawa M, Wieland SF. Pathogenesis of hepatitis B virus infection.
Pathol Biol (Paris) 2010; 58:258-266.
15.
Maini MK, Boni C, Ogg GS, King AS, Reignat S, Lee CK, et al. Direct ex vivo
analysis of hepatitis B virus-specific CD8 T cells associated with the control of
infection. Gastroenterology 1999;117:1-13.
16.
Parker DC. T cell-dependent B cell activation. Annu Rev Immunol 1993;11:331-60.
17.
Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Ann Rev Immunol
1995;13:29-60.
18.
Milich DR, Jones JE, Hughes JL, Price J, Raney AK, McLachlan A. Is a function
of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?
Proc Natl Acad Sci USA 1990;87:6599-604.
19.
Maini M, Boni C, Lee C, Larrubia J, Reignat S, Ogg G et al. The role of virus-
specific CD8(+) cells in liver damage and viral control during persistent hepatitis
B virus infection. J Exp Med 2000;191:1269-1280.
20. Chen MT, Billaud JN, Sallberg M, Guidotti LG, Chisari FV, Jones J, et al. A
function of the hepatitis B virus precore protein is to regulate the immune
response to the core antigen. Proc Natl Acad Sci USA 2004;101:14913-8.
1...,40,41,42,43,44,45,46,47,48,49 51,52,53,54,55,56,57,58,59,60,...328